Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/13/2010EP2134720B1 Heterocyclic spiro-compounds
10/13/2010EP2094696B1 5-sulfanylmethyl-[1,2,4] triazol[1, 5-a] pyrimidin-7-ol derivatives as cxcr2 antagonists
10/13/2010EP2041133B1 Derivatives of imidazo [1,2-a]pyridine-2-carboxamides, preparation method thereof and use of same in therapeutics
10/13/2010EP2004658B1 Condensed imidazole derivatives as aromatase inhibitors
10/13/2010EP1937667B1 Benzimidazoles useful as inhibitors of protein kinases
10/13/2010EP1931358B1 Pharmaceutical combinations containing lamivudine, stavudine and nevirapine
10/13/2010EP1902039B1 6-oxazol-4-ylmethoxy-alkoxymethyl substituted benzoic acid derivatives forming ppar ligands, methods for production and the use thereof in the form of drugs
10/13/2010EP1891056B1 Novel compounds
10/13/2010EP1783129B1 Spiropiperidyl rifamycins for the treatment of microbacterial infections
10/13/2010EP1781284B1 Use of the combination comprising temozolomide and tnf-alpha for treating glioblastoma
10/13/2010EP1532141B1 2-pyrrolidin-2-yl- [1,3,4]-oxadiazole derivatives and the use of the same as antidepressants
10/13/2010EP1499618B1 Furyl compounds
10/13/2010EP1480644B1 Novel heterocyclic compounds which are active as inhibitors of beta+lactamases
10/13/2010EP1458734B1 Derivatives of isoindigo, indigo and indirubin and use in treating cancer
10/13/2010EP1370537B1 Metalloproteinase inhibitors
10/13/2010EP1255553B1 Use of trilostane or keto-trilostane in combination with an antioestrogen in the treatment of a hormone-dependent condition.
10/13/2010EP1154022B1 Novel substance originating in basidiomycete culture, process for producing the same and use thereof
10/13/2010EP1037642B9 Modified polysaccharides exhibiting altered biological recognition
10/13/2010CN1993131B Film-coated tablet
10/13/2010CN1976691B Cysteamines for treating complications of hypercholesterolemia and diabetes
10/13/2010CN1972918B Pyrimidine derivatives
10/13/2010CN1947739B Traditional Chinese medicine composition for treating dermal titillation and chronic eczema and its preparation method
10/13/2010CN1946405B Use of 9h-purine-2,6-diamine derivatives in the treatment of proliferative diseases and novel 9h-purine-2,6-diamine derivatives
10/13/2010CN1939922B 5H-thiophene [3,4-C] pyrrole-4,6-diketone derivative for inhibiting cell release tumor necrosis factor
10/13/2010CN1927202B Vitamin E nicotinate microcapsule and its preparing process
10/13/2010CN1919207B Gariic and medlar capsule
10/13/2010CN1896100B Liver regenerated factor and its use
10/13/2010CN1891212B Oral preparation and its preparing method
10/13/2010CN1875979B Soft capsule of hippophae rhamnoides and preparation process thereof
10/13/2010CN1843418B Traditional Chinese medicine extract for treating gastroenteritis, its preparation method and traditional Chinese medicine composition containing same
10/13/2010CN1823890B Formula of oral Chinese medicine used for treating virus myocarditis
10/13/2010CN1805939B Benzazepine derivatives useful for the treatment of 5HT2C receptor associated diseases
10/13/2010CN1795845B Slow release microsphere preparation of derivative of 3,3 - diphenyl propylamine as receptor antagon of toadstool alkali in use for injection
10/13/2010CN1761465B Method for manufacturing coated formulation
10/13/2010CN1754535B Paclitaxel analog microsphere for topical injection, its preparation method and uses
10/13/2010CN1646473B Novel curcumin analogues and uses thereof
10/13/2010CN101861328A Aminooxime derivatives of 2- and/or 4-substituted androstanes and androstenes as medicaments for cardiovascular disorders
10/13/2010CN101861327A An amorphous form of an anti-inflammatory compound
10/13/2010CN101861324A Beta-lactamase inhibitors
10/13/2010CN101861321A Pyrrolo [2, 3 -D] pyrimidin derivatives as protein kinase B inhibitors
10/13/2010CN101861319A Benzazepinone compound
10/13/2010CN101861318A Method of synthesis of morpholino oligomers
10/13/2010CN101861316A Imidazo[1,2-a]pyridine derivatives and their use as positive allosteric modulators of MGLUR2 receptors
10/13/2010CN101861314A Xinafoate salt of N4-[(2, 2-difluoro-4N-benz0 [1,4] 0xazin-3-one) -6-yl] -5-fluoro-N2- [3- (methylaminocar bonylmethyleneoxy) phenyl] 2, 4-pyrimidinediamine
10/13/2010CN101861313A Phenyl amino pyrimidine compounds and uses thereof
10/13/2010CN101861312A 2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines and pyridines and 3-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-2-phenyl pyridines as 5-HT7 receptor antagonists
10/13/2010CN101861311A 5-pyridinone substituted indazoles
10/13/2010CN101861309A SALARIN and TULEARIN, compositions and uses thereof
10/13/2010CN101861307A Certain substituted amides, method of making, and method of use thereof
10/13/2010CN101861304A New thrombin function compounds and pharmaceutical compositions based on them
10/13/2010CN101861303A Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof
10/13/2010CN101861302A Pyrrolidine aryl-ether as NK3 receptor antagonists
10/13/2010CN101861301A Dioxoanthracene sulphonate derivatives
10/13/2010CN101861300A Crystalline forms of tigecycline hydrochloride
10/13/2010CN101861297A Biphenyl carboxylic acids and derivatives thereof
10/13/2010CN101861187A Methods and compositions for treating dry eye
10/13/2010CN101861159A Improved antitumoral treatments
10/13/2010CN101861154A Vaginal lubricant comprising hyaluronic acid
10/13/2010CN101861153A Peritoneal dialysate
10/13/2010CN101861152A DEHA compositions for treating menopause
10/13/2010CN101861151A Cancer combination therapy with a selective inhibitor of histone deacetylase HDAC1, HDAC2 and/or HDAC3 and a microtubule stabilizer
10/13/2010CN101861150A Antifungal agents
10/13/2010CN101861149A N-(2-thiazolyl)-amide derivatives for the treatment of obesity, diabetes and cardiovascular diseases
10/13/2010CN101861148A Lidocaine tape preparation
10/13/2010CN101861147A Composition for the treatment of hypertrophic scars comprising fucose, dimethylsulfone and/or acetyl glucosamine
10/13/2010CN101861145A Stable chewing gum compositions comprising maltitol and providing rapid release of nicotine
10/13/2010CN101861144A Lipoic acid pellet composition
10/13/2010CN101861139A Topical ophthalmic or otic solution formulations containing moxifloxacin hydrochloride and dexamethasone phosphate
10/13/2010CN101857861A Molecular marker for immunological recognition and construction and application thereof
10/13/2010CN101857642A Polysaccharide derivative and vanadium complex application thereof
10/13/2010CN101857622A Adenosine derivative, and preparation method and application thereof
10/13/2010CN101857619A Novel secoiridoid compound and application in preparation of anti-inflammatory drug
10/13/2010CN101857618A Series of quinazoline sugar derivatives used as protein tyrosine kinase inhibitor, preparation method and application thereof
10/13/2010CN101857617A Quinazoline sugar derivative and preparation method and application thereof
10/13/2010CN101857613A Rupestonic acid glycolipid derivative and preparation method and applications thereof
10/13/2010CN101857598A Furocoumarin compound with hypertension activity reducing function and preparation method thereof
10/13/2010CN101857595A Quinnazolidone derivative, preparation method thereof and purpose of serving as anticarcinogen
10/13/2010CN101857594A Tetrahydropyridoindole compounds, and preparation method and application thereof
10/13/2010CN101857591A Hydrochloric acid tiagabine crystal formations and preparation method thereof
10/13/2010CN101857590A Chromone ketoside compounds and purification method and application thereof
10/13/2010CN101857589A Pyrazol-benzimidazoles derivative and application thereof
10/13/2010CN101857588A 4-aromatic aminoquinazoline derivative and purpose thereof
10/13/2010CN101857587A 2-aryl benzothiophene derivatives or pharmaceutically acceptable salts thereof, preparation method thereof, and phrmaceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as an active ingredient
10/13/2010CN101857584A Hydroxyl flavanoid compound and application thereof
10/13/2010CN101857583A Method for preparing isoflavone metal complexes and anti-tumor medical application
10/13/2010CN101857578A New crystal form of febuxostat and preparation method
10/13/2010CN101857573A Substituted quinazoline derivatives and their use as tyrosine kinase inhibitors
10/13/2010CN101857572A 4-aromatic amino pyrimidine derivative and application thereof
10/13/2010CN101857564A Method for removing dioxane from Ftibamzone raw material
10/13/2010CN101857558A Process for refining 2-aminoethanesulfonic acid from crude 2-aminoethane-sulfonic acid, 2-aminoethanesulfonic acid obtained there from and use thereof
10/13/2010CN101857554A Cinamic compounds and derivatives therefrom for the inhibition of histone deacetylase
10/13/2010CN101857542A Method for manufacturing low-lead granular zinc citrate
10/13/2010CN101857540A Method for producing adipic acid, hexamethylenediamine hydrochloride and polyhexamethylene (di)guanidine chloride from nylon-66 through depolymerization
10/13/2010CN101856499A Solution-aid system for insoluble medicinal injection and injection thereof
10/13/2010CN101856498A Anti-septic shock medicine compound and application thereof
10/13/2010CN101856495A Medical composition and mixture for treating chicken infectious bursal disease and preparation method thereof
10/13/2010CN101856493A Compound piracetam brain protein hydrolysate tablet and preparation method thereof
10/13/2010CN101856479A Chinese medicament for treating psoriasis vulgaris and preparation method thereof
10/13/2010CN101856453A Nanomedicine composition for resisting primary bronchitis virus and preparation method thereof
10/13/2010CN101856429A Medicine compound with visual fatigue relieving function and preparation method thereof